Edesa Biotech, Inc.
EDSANasdaqCIK 1540159HealthcareFiscal year ends Sep 30
Reports and events: 333 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2317:24 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001171843-26-006794 |
| 2026-10-1509:15 ET | 8-K | 8.01 Other events | 0001171843-26-006647 |
| 2026-08-2518:00 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001171843-26-005738 |
| 2026-08-2516:38 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000921895-26-002310 |
| 2026-08-2016:15 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-26-005686 |
| 2026-08-1316:40 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001171843-26-005502 |
| 2026-08-1316:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-005499 |
| 2026-06-1617:06 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001171843-26-004153 |
| 2026-06-1109:20 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-004053 |
| 2026-06-0509:25 ET | 8-K | 8.01 Other events | 0001171843-26-003931 |
| 2026-05-2916:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001171843-26-003793 |
| 2026-05-1509:08 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001171843-26-003459 |
| 2026-05-1416:50 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001171843-26-003433 |
| 2026-05-1416:40 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-003429 |
| 2026-04-0316:31 ET | DEF 14A | Proxy statementPeriod 2026-05-27 | 0001171843-26-002236 |
| 2026-03-0219:03 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000921895-26-000578 |
| 2026-03-0217:11 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001171843-26-001269 |
| 2026-02-2409:21 ET | 8-K | 8.01 Other events | 0001171843-26-001046 |
| 2026-02-1316:45 ET | 10-Q | Quarterly reportPeriod 2025-12-31 | 0001171843-26-000812 |
| 2026-02-1316:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-000810 |
| 2025-12-1216:45 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-25-007918 |
| 2025-12-1216:30 ET | 10-K | Annual reportPeriod 2025-09-30 | 0001171843-25-007914 |
| 2025-12-1216:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-007913 |
| 2025-10-2807:45 ET | 8-K | 8.01 Other events | 0001171843-25-006690 |
| 2025-09-3016:14 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001171843-25-006188 |
| 2025-09-0916:35 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-25-005800 |
| 2025-08-0816:45 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001171843-25-005236 |
| 2025-08-0816:40 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-005235 |
| 2025-05-2816:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001171843-25-003495 |
| 2025-05-1416:46 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001171843-25-003189 |
| 2025-05-1416:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-003183 |
| 2025-04-0416:22 ET | DEF 14A | Proxy statementPeriod 2025-05-28 | 0001171843-25-002028 |
| 2025-04-0416:20 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-25-002027 |
| 2025-02-1817:48 ET | SCHEDULE 13D | Ownership report, active investor | 0000921895-25-000528 |
| 2025-02-1417:16 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001171843-25-000871 |
| 2025-02-1416:46 ET | 10-Q | Quarterly reportPeriod 2024-12-31 | 0001171843-25-000866 |
| 2025-02-1416:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-000864 |
| 2025-02-1307:16 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-25-000796 |
| 2024-12-2016:40 ET | 10-K/A | Annual report, amendedPeriod 2024-09-30 | 0001171843-24-007041 |
| 2024-12-1316:45 ET | 10-K | Annual reportPeriod 2024-09-30 | 0001171843-24-006946 |
| 2024-12-1316:40 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-006945 |
| 2024-11-0120:50 ET | SC 13D/A | Ownership report, active investor, amended | 0001171843-24-005965 |
| 2024-10-3108:30 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001171843-24-005928 |
| 2024-10-0416:55 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001171843-24-005515 |
| 2024-08-0916:45 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001171843-24-004651 |
| 2024-08-0916:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-004649 |
| 2024-06-2408:31 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-24-008062 |
| 2024-05-3017:04 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001654954-24-007083 |
| 2024-05-1016:46 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001654954-24-005971 |
| 2024-05-1016:23 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-24-005965 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 17:02 ET. Listed shows no prices and gives no investment advice.